Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELARIS EM-III: Elagolix Extension in Endometriosis
NCT01760954Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Dec 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of elagolix in endometriosis, sponsored by AbbVie Inc.. Started Dec 2012; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01760954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01760954.